Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Windtree Therapeutics received early financing of $30.0M on 2013-02-13.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Debt | $30M | 02/2013 |
| Grant | $1.9M | 06/2014 |
| Grant | $3M | 10/2014 |
| Post Ipo Equity | $10.5M | 02/2017 |
| Post Ipo Equity | $2.6M | 04/2018 |
| Grant | $700K | 05/2018 |
| Post Ipo Equity | $26.4M | 12/2019 |
| Post Ipo Equity | $23M | 05/2020 |
| Post Ipo Equity | $30M | 03/2021 |
| Investors | Security type |
|---|---|
| Deerfield Management | Post Ipo Debt |
| National Institutes of Health (NIH) | Grant |
| National Institutes of Health (NIH) | Grant |
| National Institutes of Health (NIH) | Grant |
| VMS Asset Management | Post Ipo Equity |
Windtree Therapeutics's top competitor, TCR² Therapeutics, earned an annual revenue of $661.1M.
Windtree Therapeutics's smallest competitor is Edgewise Therapeutics with revenue of $30.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| BioTime | - | $3.4M | 101 | - |
| Codiak BioSciences | - | $22.9M | 115 | - |
| Edgewise Therapeutics | - | $30,000 | 45 | - |
| TCR² Therapeutics | - | $661.1M | 118 | - |
| Leap Therapeutics | - | $1.5M | 30 | - |
| Cognition Therapeutics | - | $19.5M | 30 | - |
| Civitas Therapeutics | - | $72.9M | 20 | - |
| Satsuma Pharmaceuticals | - | $492.9M | 5 | - |
| Tarsa Therapeutics | - | $1.6M | 10 | - |
Zippia gives an in-depth look into the details of Windtree Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Windtree Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Windtree Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Windtree Therapeutics. The data presented on this page does not represent the view of Windtree Therapeutics and its employees or that of Zippia.
Windtree Therapeutics may also be known as or be related to WINDTREE THERAPEUTICS INC /DE and Windtree Therapeutics.